Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,268 signal articles · 40 in last 24h · 115,355 total before filter · latest 2h ago
40last 24h
1786last 7d
298● bullish (7d)
169● bearish (7d)
205publishers
AllMacro317Earnings833M&A103Regulatory25Product16Analyst25
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearishshow all (incl. clickbait)
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?
Barrons.com15d agobullish
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.

The biggest myth about the S&P 500 run just got debunked
TheStreet16d agoneutral
The biggest myth about the S&P 500 run just got debunked

The S&P 500 has spent much of the year under scrutiny as elevated valuations and signs of overextension fueled expectations of a market correction. After the index broke through 7,000 for the first time and kept climbing to new records, those fears intensified across financial media. The ...

Morgan Stanley delivers strong new verdict on RTX stock after earnings
TheStreet16d agoneutral
Morgan Stanley delivers strong new verdict on RTX stock after earnings

Besides this second quarter, I had the chance to cover Morgan Stanley's note on RTX in April after their impressive Q1. Morgan Stanley cut RTX's price target to $220 but maintained an Overweight rating, viewing the post-earnings dip as a "buying opportunity."Fast forward to this Q2 coverage: RTX ...